111 related articles for article (PubMed ID: 9335018)
1. Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy.
Shirabe S; Nakamura T; Tsujino A; Nishiura Y; Furuya T; Goto H; Suenaga A; Nakane S; Yoshimura T; Nagataki S
J Neurol Sci; 1997 Oct; 151(1):97-101. PubMed ID: 9335018
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy.
Fujimoto T; Nakamura T; Furuya T; Nakane S; Shirabe S; Kambara C; Hamasaki S; Yoshimura T; Eguchi K
Intern Med; 1999 Sep; 38(9):717-21. PubMed ID: 10480302
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline down-regulates adhesion molecule expression and inflammatory cytokine production in cultured peripheral blood mononuclear cells from patients with HTLV-I-associated myelopathy.
Tsujino A; Nakamura T; Nishiura Y; Shirabe S; Furuya T; Goto H; Kawakami A; Eguchi K; Nagataki S
J Neuroimmunol; 1997 Mar; 73(1-2):191-6. PubMed ID: 9058776
[TBL] [Abstract][Full Text] [Related]
4. A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis.
Matsuzaki T; Saito M; Usuku K; Nose H; Izumo S; Arimura K; Osame M
J Neurol Sci; 2005 Oct; 237(1-2):75-81. PubMed ID: 15961107
[TBL] [Abstract][Full Text] [Related]
5. Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
Alberti C; Cartier L; Valenzuela MA; Puente J; Tanaka Y; Ramirez E
J Med Virol; 2011 Sep; 83(9):1641-9. PubMed ID: 21739457
[TBL] [Abstract][Full Text] [Related]
6. Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Sato T; Coler-Reilly ALG; Yagishita N; Araya N; Inoue E; Furuta R; Watanabe T; Uchimaru K; Matsuoka M; Matsumoto N; Hasegawa Y; Yamano Y
N Engl J Med; 2018 Feb; 378(6):529-538. PubMed ID: 29414279
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Nakagawa M; Nakahara K; Maruyama Y; Kawabata M; Higuchi I; Kubota H; Izumo S; Arimura K; Osame M
J Neurovirol; 1996 Oct; 2(5):345-55. PubMed ID: 8912211
[TBL] [Abstract][Full Text] [Related]
8. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
[TBL] [Abstract][Full Text] [Related]
9. Heparin treatment in patients with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy: a preliminary study.
Nagasato K; Nakamura T; Ichinose K; Nishiura Y; Ohishi K; Shibayama K; Watanabe H; Tsujihata M; Nagataki S
J Neurol Sci; 1993 Apr; 115(2):161-8. PubMed ID: 8482978
[TBL] [Abstract][Full Text] [Related]
10. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
[TBL] [Abstract][Full Text] [Related]
11. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
[TBL] [Abstract][Full Text] [Related]
12. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Lehky TJ; Levin MC; Kubota R; Bamford RN; Flerlage AN; Soldan SS; Leist TP; Xavier A; White JD; Brown M; Fleisher TA; Top LE; Light S; McFarland HF; Waldmann TA; Jacobson S
Ann Neurol; 1998 Dec; 44(6):942-7. PubMed ID: 9851439
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
[TBL] [Abstract][Full Text] [Related]
14. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.
Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E
J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614
[TBL] [Abstract][Full Text] [Related]
15. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
16. Prosultiamine for treatment of lower urinary tract dysfunction accompanied by human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis.
Matsuo T; Miyata Y; Nakamura T; Satoh K; Sakai H
Int J Urol; 2018 Jan; 25(1):54-60. PubMed ID: 28965354
[TBL] [Abstract][Full Text] [Related]
17. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
[TBL] [Abstract][Full Text] [Related]
18. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
[TBL] [Abstract][Full Text] [Related]
19. Human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis: viral load and muscle tone are correlated.
Zunt JR; Montano SM; Beck I; Alarcón JO; Frenkel LM; Bautista CT; Price R; Longstreth WT
J Neurovirol; 2006 Dec; 12(6):466-71. PubMed ID: 17162662
[TBL] [Abstract][Full Text] [Related]
20. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
